Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > News > Key mechanism identified for reducing chronic inflammation in cardiovascular diseases

Key mechanism identified for reducing chronic inflammation in cardiovascular diseases

Date time 13 April, 2023
News Type News type Media release
Dr Joyce Chiu
Dr Joyce Chiu
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.

Published in the prestigious journal Circulation Research, the study investigated the movement of neutrophils, a type of white blood cell that is an essential part of the immune system.

Neutrophils, the first responders when there’s an injury or infection, move from blood vessels to the site of injury and initiate inflammation and healing. However, prolonged retention of neutrophils, such as at the site of vascular injury, can result in chronic inflammation and a build-up of atherosclerotic plaques that can lead to strokes and heart attacks.

Dr Joyce Chiu, lead author of the study, from the ACRF Centenary Cancer Research Centre, said that the team had uncovered the method by which neutrophils unstick from blood vessels as they move towards the site of injury. This mechanism, she said, could be potentially harnessed to reduce chronic inflammation by preventing the movement of neutrophils to certain areas of the body.

“Molecules known as integrins help neutrophils stick to the walls of blood vessels, to prevent the cells from being carried away by blood flow. To move to the site of injury, neutrophils must stick and unstick from blood vessel walls. While we knew how integrins helped neutrophils stick, we did not know how they unstick,” said Dr Chiu.

According to Dr Chiu, the study discovered that a molecule called protein disulfide isomerase (PDI), secreted by neutrophils, plays a crucial role in helping the cells unstick from blood vessels as they move towards the site of injury.

Dr Chiu believes that this finding suggests that PDI could be a target for new drugs to treat chronic inflammation in diseases including cardiovascular diseases.

“New drugs can be designed to inhibit PDI, to keep neutrophils from ‘unsticking’ and migrating from blood vessel walls. Preventing neutrophils from moving around can help prevent chronic inflammation by reducing their ability to accumulate at sites of injury or infection,” Dr Chiu said.

“Our research could pave the way for new treatments and management strategies that are able to limit the extent of inflammation, and potentially improve outcomes for individuals with chronic inflammatory and cardiovascular conditions.”

Themes

  • Cardiovascular

    Cardiovascular
  • Inflammation

    Inflammation

Programs

  • ACRF Centenary Cancer Research Centre

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw, Media and Communications Manager

Phone number Phone Number 0402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Key mechanism identified for reducing chronic inflammation in cardiovascular diseases

Download

Recent Stories

  • New funding to advance gene therapies

    Researchers at the Centenary Institute and the Sydney Local Health District (SLHD) have been awarded $500,000 from CUREator, Australia’s national biotech incubator, to develop new technology to improve the safe and effective delivery of gene therapy.
    News Type: Media release
    Date 24 May 2023
  • ABC Health Report interviews Professor John Rasko AO

    Professor John Rasko AO, Head of the Gene and Stem Cell Therapy Program at the Centenary Institute has been interviewed by Dr Norman Swan on Radio National’s Health Report about gene therapy treatment for Duchenne muscular dystrophy as well as the status of gene therapy in the clinic generally.
    News Type: Media coverage
    Date 16 May 2023
  • Prestigious editorial board appointment for Associate Professor Andy Philp

    Associate Professor Andy Philp – Director of the Centenary Institute’s Centre for Healthy Ageing and an internationally renowned expert in skeletal muscle wasting disorders ¬ has been invited onto the editorial board of the respected Journal of Cachexia, Sarcopenia and Muscle (JCSM).
    News Type: Research News
    Date 08 May 2023
  • How can cardiovascular healthcare be ‘greener’?

    A new review has shown how medical professionals in cardiology can help reduce healthcare’s carbon footprint, by making small, low-cost changes in how they work. The review, published today in the prestigious Open Heart journal, explores the environmental impact of cardiovascular healthcare.
    News Type: Media release
    Date 03 May 2023

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram